Genpact Limited (G)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 631,255 | 429,658 | 407,908 | 363,326 | 353,404 | 336,777 | 343,320 | 374,354 | 369,448 | 371,345 | 354,394 | 313,851 | 308,276 | 315,492 | 318,177 | 329,738 | 304,881 | 301,830 | 287,313 | 278,165 |
| Total stockholders’ equity | US$ in thousands | 2,248,390 | 2,009,450 | 1,932,860 | 1,925,330 | 1,826,160 | 1,731,850 | 1,750,440 | 1,847,390 | 1,897,130 | 1,952,890 | 1,838,970 | 1,749,620 | 1,834,230 | 1,777,180 | 1,660,610 | 1,573,080 | 1,689,170 | 1,605,680 | 1,583,370 | 1,495,170 |
| ROE | 28.08% | 21.38% | 21.10% | 18.87% | 19.35% | 19.45% | 19.61% | 20.26% | 19.47% | 19.02% | 19.27% | 17.94% | 16.81% | 17.75% | 19.16% | 20.96% | 18.05% | 18.80% | 18.15% | 18.60% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $631,255K ÷ $2,248,390K
= 28.08%
Genpact Ltd's return on equity (ROE) has shown a varying trend over the past eight quarters. In Q4 2023, the ROE stood at 28.08%, reflecting a significant increase compared to the previous quarters. This suggests that the company generated a higher net income relative to its shareholders' equity in that period.
In the preceding quarters, Genpact's ROE ranged from 18.87% to 21.38%, indicating relatively stable performance in terms of generating profitability from shareholders' investments. However, Q4 2023 stands out as a particularly strong quarter in terms of return on equity.
Overall, Genpact Ltd's ROE performance over the past two years has been relatively consistent, staying within the range of 19.35% to 21.38%. This indicates that the company has been effectively utilizing its equity to generate profits for its shareholders. The notable increase in ROE in Q4 2023 suggests improved profitability and efficiency in utilizing shareholder funds during that period.
Peer comparison
Dec 31, 2023